Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 2587-2591, April 15, 2008. doi: 10.1158/0008-5472.CAN-08-0264
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Boyerinas, B.
Right arrow Articles by Peter, M. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyerinas, B.
Right arrow Articles by Peter, M. E.

Priority Reports

Identification of Let-7–Regulated Oncofetal Genes

Benjamin Boyerinas1, Sun-Mi Park1, Noam Shomron2, Mads M. Hedegaard3, Jeppe Vinther3, Jens S. Andersen4, Christine Feig1, Jinbo Xu5, Christopher B. Burge2 and Marcus E. Peter1

1 The Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois; 2 Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts; 3 Molecular Evolution Group, Institute of Molecular Biology, University of Copenhagen, Copenhagen, Denmark; 4 Center for Experimental Bioinformatics, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark; and 5 The Toyota Technological Institute at Chicago, Chicago, Illinois

Requests for reprints: Marcus E. Peter, The Ben May Department for Cancer Research, The University of Chicago, 924 East 57th Street, R112, Chicago, IL 60637. Phone: 773-702-4728; Fax: 773-702-3701; E-mail: mpeter{at}uchicago.edu.

Key Words: cancer progression • IMP-1 • miRNA

MicroRNAs (miRNA) are small RNA molecules of ~20 to 22 nucleotides that reduce expression of proteins through mRNA degradation and/or translational silencing. Each known miRNA has a large number of predicted targets. Members of the let-7/miR-98 family of miRNAs are up-regulated at the end of embryonic development. Let-7 is often down-regulated early during cancer development, suggesting that let-7–regulated oncofetal genes (LOG) may become reexpressed in cancer cells. Using comparative bioinformatics, we have identified 12 conserved LOGs that include HMGA2 and IMP-1/CRD-BP. IMP-1 has growth-promoting activities through stabilization of c-myc mRNA. We experimentally confirmed that IMP-1 is a direct let-7 target that promotes cell growth and motility of tumor cells, and we confirmed by proteomics analysis that IMP-1 and HMGA2 are major miRNA targets. Our data suggest that a substantial part of the growth inhibitory activities of let-7 comes from suppressing the expression of IMP-1. LOGs could be novel therapeutic targets and potential biomarkers for cancer treatment. [Cancer Res 2008;68(8):2587–91]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.